Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003593
Status:
COMPLETED
Last Update Posted:
2013-06-27
First Post:
1999-11-01
Brief Title:
Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Sponsor:
Childrens Oncology Group
Organization:
Childrens Oncology Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MyelodysplasticMyeloproliferative Neoplasms |
| Leukemia |
| Myelodysplastic Syndromes |
Keywords:
| Name | View |
|---|---|
| secondary myelodysplastic syndromes | View |
| childhood myelodysplastic syndromes | View |
| untreated childhood acute myeloid leukemia and other myeloid malignancies | View |
| childhood acute myeloblastic leukemia without maturation M1 | View |
| childhood acute myeloblastic leukemia with maturation M2 | View |
| childhood acute myelomonocytic leukemia M4 | View |
| childhood acute erythroleukemia M6 | View |
| childhood acute megakaryocytic leukemia M7 | View |
| refractory anemia | View |
| refractory anemia with ringed sideroblasts | View |
| refractory anemia with excess blasts | View |
| refractory anemia with excess blasts in transformation | View |
| de novo myelodysplastic syndromes | View |
| childhood acute minimally differentiated myeloid leukemia M0 | View |
| childhood acute monocytic leukemia M5b | View |
| childhood acute monoblastic leukemia M5a | View |
| myelodysplasticmyeloproliferative neoplasm unclassifiable | View |
| juvenile myelomonocytic leukemia | View |
| chronic myelomonocytic leukemia | View |